Next, we performed a molecular analysis of expressed TRB gene rearrangements in CD3+ CD8+ TCR-Vβ+ cell populations sorted directly ex vivo from T-LGLL and dasatinib-treated CML patients. Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.